Why the study?
Does conditional deletion of cardiomyocyte PPARγ enhance myocardial ischemia-reperfusion injury in mice?
Population
Mice with α-myosin heavy chain-restricted Cre-mediated PPARγ deficiency
Comparison
Tamoxifen treatment for 4 days to induce PPARγ… vs Oil diluent vehicle treatment, followed by…
Design
Preclinical
Follow-up
2 hours (reperfusion phase)
Authors
Loading...
Supports PPARγ cardioprotection in murine ischemia-reperfusion injury; hypothesis-generating for human translation.
Does conditional deletion of cardiomyocyte PPARγ enhance myocardial ischemia-reperfusion injury in mice?
Cardiomyocyte-specific deletion of PPARγ exacerbates myocardial ischemia-reperfusion injury, highlighting its protective role against inflammation.
Hobson et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: